| Nov 6 |
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
|
| Nov 5 |
Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024
|
| Nov 4 |
Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates
|
| Oct 29 |
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas
|
| Oct 4 |
Plus Therapeutics files for $100M mixed securities shelf
|
| Oct 1 |
Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting
|
| Sep 18 |
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
|
| Sep 4 |
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 13 |
Plus Therapeutics Q2 2024 Earnings Preview
|
| Aug 13 |
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
|
